📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study. (2023)

First Author: Qian GY

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jvacx.2023.100321

PubMed Identifier: 37409192

Publication URI: http://europepmc.org/abstract/MED/37409192

Type: Journal Article/Review

Volume: 14

Parent Publication: Vaccine: X

ISSN: 2590-1362